174 related articles for article (PubMed ID: 18440304)
1. LYRIC/AEG-1 overexpression modulates BCCIPalpha protein levels in prostate tumor cells.
Ash SC; Yang DQ; Britt DE
Biochem Biophys Res Commun; 2008 Jun; 371(2):333-8. PubMed ID: 18440304
[TBL] [Abstract][Full Text] [Related]
2. LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals.
Thirkettle HJ; Girling J; Warren AY; Mills IG; Sahadevan K; Leung H; Hamdy F; Whitaker HC; Neal DE
Clin Cancer Res; 2009 May; 15(9):3003-13. PubMed ID: 19383828
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2.
Liu J; Yuan Y; Huan J; Shen Z
Oncogene; 2001 Jan; 20(3):336-45. PubMed ID: 11313963
[TBL] [Abstract][Full Text] [Related]
4. Nuclear LYRIC/AEG-1 interacts with PLZF and relieves PLZF-mediated repression.
Thirkettle HJ; Mills IG; Whitaker HC; Neal DE
Oncogene; 2009 Oct; 28(41):3663-70. PubMed ID: 19648967
[TBL] [Abstract][Full Text] [Related]
5. AEG-1/MTDH/LYRIC: signaling pathways, downstream genes, interacting proteins, and regulation of tumor angiogenesis.
Emdad L; Das SK; Dasgupta S; Hu B; Sarkar D; Fisher PB
Adv Cancer Res; 2013; 120():75-111. PubMed ID: 23889988
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity.
Kikuno N; Shiina H; Urakami S; Kawamoto K; Hirata H; Tanaka Y; Place RF; Pookot D; Majid S; Igawa M; Dahiya R
Oncogene; 2007 Dec; 26(55):7647-55. PubMed ID: 17563745
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the localisation and function of the oncogene LYRIC/AEG-1 by ubiquitination at K486 and K491.
Luxton HJ; Barnouin K; Kelly G; Hanrahan S; Totty N; Neal DE; Whitaker HC
Mol Oncol; 2014 May; 8(3):633-41. PubMed ID: 24529480
[TBL] [Abstract][Full Text] [Related]
8. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis.
Emdad L; Sarkar D; Su ZZ; Randolph A; Boukerche H; Valerie K; Fisher PB
Cancer Res; 2006 Feb; 66(3):1509-16. PubMed ID: 16452207
[TBL] [Abstract][Full Text] [Related]
9. Novel Thiosemicarbazones Inhibit Lysine-Rich Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) Coisolated (LYRIC) and the LYRIC-Induced Epithelial-Mesenchymal Transition via Upregulation of N-Myc Downstream-Regulated Gene 1 (NDRG1).
Xi R; Pun IH; Menezes SV; Fouani L; Kalinowski DS; Huang ML; Zhang X; Richardson DR; Kovacevic Z
Mol Pharmacol; 2017 May; 91(5):499-517. PubMed ID: 28275050
[TBL] [Abstract][Full Text] [Related]
10. The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repair.
Lu H; Guo X; Meng X; Liu J; Allen C; Wray J; Nickoloff JA; Shen Z
Mol Cell Biol; 2005 Mar; 25(5):1949-57. PubMed ID: 15713648
[TBL] [Abstract][Full Text] [Related]
11. AEG-1/MTDH/LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expression.
Lee SG; Kang DC; DeSalle R; Sarkar D; Fisher PB
Adv Cancer Res; 2013; 120():1-38. PubMed ID: 23889986
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance mediated by AEG-1/MTDH/LYRIC.
Meng X; Thiel KW; Leslie KK
Adv Cancer Res; 2013; 120():135-57. PubMed ID: 23889990
[TBL] [Abstract][Full Text] [Related]
13. AEG-1/MTDH/LYRIC: A Promiscuous Protein Partner Critical in Cancer, Obesity, and CNS Diseases.
Emdad L; Das SK; Hu B; Kegelman T; Kang DC; Lee SG; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():97-132. PubMed ID: 27451125
[TBL] [Abstract][Full Text] [Related]
14. The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease.
Noch EK; Khalili K
Adv Cancer Res; 2013; 120():159-92. PubMed ID: 23889991
[TBL] [Abstract][Full Text] [Related]
15. AEG-1/MTDH/LYRIC in liver cancer.
Sarkar D
Adv Cancer Res; 2013; 120():193-221. PubMed ID: 23889992
[TBL] [Abstract][Full Text] [Related]
16. Emerging Role and Clinicopathological Significance of AEG-1 in Different Cancer Types: A Concise Review.
Sriramulu S; Sun XF; Malayaperumal S; Ganesan H; Zhang H; Ramachandran M; Banerjee A; Pathak S
Cells; 2021 Jun; 10(6):. PubMed ID: 34203598
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic roles of AEG-1/MTDH/LYRIC in breast cancer.
Wan L; Kang Y
Adv Cancer Res; 2013; 120():113-34. PubMed ID: 23889989
[TBL] [Abstract][Full Text] [Related]
18. AEG-1/MTDH/LYRIC: clinical significance.
Sarkar D; Fisher PB
Adv Cancer Res; 2013; 120():39-74. PubMed ID: 23889987
[TBL] [Abstract][Full Text] [Related]
19. Metadherin (AEG-1/MTDH/LYRIC) expression: Significance in malignancy and crucial role in colorectal cancer.
Abdel Ghafar MT; Soliman NA
Adv Clin Chem; 2022; 106():235-280. PubMed ID: 35152973
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of G1 to S cell cycle progression by BCCIP beta.
Meng X; Liu J; Shen Z
Cell Cycle; 2004 Mar; 3(3):343-8. PubMed ID: 14726710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
